MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Free Cash flow
-$2,876K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Proceeds from notes payable-Nonr...
    • Proceeds from deferred stock iss...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Payments on short-term notes pay...
    • Purchase of marketable securitie...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-3,306
-1,690
-5,848
-2,344
Depreciation and amortization
382
405
527
528
Stock-based compensation
266
64
79
70
Amortization of operating right-of-use assets
254
97
-
-
Change in fair value of minority equity interest
0
-2,302
-
-
Change in fair value of deferred consideration
318
2,877
-
-
Change in fair value of deferred stock issuance liability
-46
-
-
-
Change in fair value of royalties payable due to related parties
0
0
7,813
726
Change in fair value of convertible notes payable
-
-
2
-
Loss on impairment of intangible assets
-
-
6,995
-
Change in fair value of trading debt securities
0
-
-681
107
Loss on debt extinguishment
-105
-
-3,260
-
Unrealized gains and losses on marketable securities, net
378
-
-
-
Deferred income tax benefit
-312
-174
-214
78
Acquired in-process research and development
0
0
0
0
Amortization of discount on note payable
-
-
18
17
Accretion of discount on note payable
85
28
-
-
Accounts receivable
-141
105
32
8
Inventories
31
-19
57
-4
Prepaid expenses and other assets
82
349
-193
83
Operating lease liabilities
-136
-97
1
-1
Current portion of royalties payable due to related parties
11
-42
12
-7
Accounts payable
368
-514
492
303
Accrued expenses
-91
119
134
30
Deferred revenue
19
-45
-
-
Interest payable-Related Party
49
48
47
48
Interest payable-Variable Interest Entity Not Primary Beneficiary
15
15
15
15
Interest payable-Nonrelated Party
52
-
-
-
Net cash used in operating activities
-2,861
-2,796
-1,512
-2,183
Purchase of acquired in-process research and development
0
103
82
28
Purchase of marketable securities
1,000
-
-
-
Purchases of property and equipment
15
6
0
0
Proceeds from sales of marketable securities
182
-
300
-
Acquisition, net of cash acquired
0
1,210
-
-
Net cash used in investing activities
-833
-1,319
218
-28
Proceeds from issuance of series b convertible preferred stock and other equity-classified warrants, net of issuance costs-Series BConvertible Preferred Stock
-
-
0
0
Proceeds from issuance of common stock-September2024Public Offering
-
-
0
0
Proceeds from issuance of common stock-The2024Inducement Offer
-
-
0
-
Proceeds from issuance of common stock and other equity-classified contracts from the september 2024 public offering, net of issuance costs
-
-
-
2,174
Proceeds from issuance of common stock-Atm Offering
-
-
3,751
-
Proceeds from issuance of common stock and equity-classified contracts, net of issuance costs-Common Stock And Equity Classified Contracts
3,188
3,731
-
-
Proceeds from notes payable due to related parties
-
-
0
300
Proceeds from notes payable
-
835
61
0
Proceeds from deferred stock issuance payable
601
-
-
-
Proceeds from issuance of convertible notes payable
-
-
300
-
Proceeds from exercise of warrants (see note 13)
0
401
0
-
Payments on short-term notes payable
1,861
499
61
26
Proceeds from notes payable-Related Party
400
-
-
-
Payments on convertible notes payable
403
-
-
-
Payments on notes payable
0
-
-
-
Proceeds from notes payable-Nonrelated Party
2,806
-
-
-
Net cash provided by financing activities
3,896
4,468
307
2,448
Net change in cash and cash equivalents
202
353
-987
237
Cash and cash equivalents, beginning of period
441
88
1,075
2,873
Cash and cash equivalents, end of period
643
441
88
1,075
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock and...$3,188K Proceeds from notespayable-Nonrelated Party$2,806K Proceeds from deferredstock issuance...$601K Proceeds from notespayable-Related Party$400K Net cash provided byfinancing activities$3,896K (50.48%↑ Y/Y)Canceled cashflow$3,099K Net change in cashand cash...$202K (109.93%↑ Y/Y)Canceled cashflow$3,694K Payments on short-termnotes payable$1,861K (1132.45%↑ Y/Y)something is missing-$835K Payments on convertiblenotes payable$403K Depreciation andamortization$382K (-63.96%↓ Y/Y)Accounts payable$368K (1.94%↑ Y/Y)Stock-based compensation$266K (40.74%↑ Y/Y)Amortization of operatingright-of-use assets$254K Accounts receivable-$141K (-413.33%↓ Y/Y)Loss on debtextinguishment-$105K Accretion of discount onnote payable$85K Interestpayable-Nonrelated Party$52K Interestpayable-Related Party$49K (-45.56%↓ Y/Y)Change in fair value ofdeferred stock issuance...-$46K Deferred revenue$19K Interestpayable-Variable Interest Entity...$15K (66.67%↑ Y/Y)Current portion ofroyalties payable due to...$11K (-21.43%↓ Y/Y)Proceeds from sales ofmarketable securities$182K Net cash used inoperating activities-$2,861K (37.82%↑ Y/Y)Net cash used ininvesting activities-$833K (-3521.74%↓ Y/Y)Canceled cashflow$1,793K Canceled cashflow$182K Net loss-$3,306K (65.21%↑ Y/Y)Purchase of marketablesecurities$1,000K Unrealized gains and losseson marketable...$378K Change in fair value ofdeferred consideration$318K Deferred income taxbenefit-$312K (81.36%↑ Y/Y)Operating leaseliabilities-$136K (-3300.00%↓ Y/Y)Accrued expenses-$91K (-506.67%↓ Y/Y)Prepaid expenses andother assets$82K (156.55%↑ Y/Y)Inventories$31K (24.00%↑ Y/Y)Purchases of property andequipment$15K (-11.76%↓ Y/Y)

Catheter Precision, Inc. (VTAK)

Catheter Precision, Inc. (VTAK)